Clinical trial
COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media…
NCT00466947 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00466947 |
|---|---|
| Title | COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine |
| Official title | COMPAS: A Phase III Study to Demonstrate Efficacy of GSK Biologicals' 10-valent Pneumococcal Vaccine (GSK1024850A) Against Community Acquired Pneumonia and Acute Otitis Media |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infections, Streptococcal |
| Intervention type | Biological |
| Interventions | Pneumococcal conjugate vaccine GSK1024850A, Havrix, Engerix-B, Infanrix hexa, GSK Biologicals' DTPa-IPV/Hib vaccine |
| Enrollment | 23,802 |
| Start date | Jun 28, 2007 |
| Primary completion | Aug 31, 2010 |
| Completion | Jul 28, 2011 |
| First posted | Apr 27, 2007 |
| Last update posted | Jul 16, 2019 |
| Countries | Argentina, Colombia, Panama |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: